Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,1705,37,11.45 [5.47-23.96],9.708307798296063e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,1652,36,2.01 [1.58-2.54],8.962215662596855e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBP,Protein AMBP,1738,39,17.78 [7.07-44.70],9.539961115213014e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,1733,39,7.28 [4.18-12.66],2.163282090718735e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,1675,38,5.83 [3.24-10.51],4.282703120713504e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSG,Basigin,1736,37,17.18 [7.51-39.28],1.598156405060504e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,1726,37,6.77 [4.03-11.38],5.243789898703252e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,1713,36,6.70 [3.55-12.64],4.181069315158093e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA12,Carbonic anhydrase 12,1722,38,3.24 [2.27-4.62],1.0667337339004927e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA14,Carbonic anhydrase 14,1740,39,3.96 [2.42-6.50],4.745931426733702e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA4,Carbonic anhydrase 4,1742,39,10.22 [4.43-23.60],5.080983535307778e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN3,CCN family member 3,1734,39,5.15 [3.17-8.35],3.262082421773097e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN4,CCN family member 4,1740,39,5.20 [3.11-8.68],2.8835483631896676e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,1703,39,3.89 [2.45-6.18],9.187586483418488e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD160,CD160 antigen,1738,37,3.91 [2.49-6.15],3.402738742184401e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD27,CD27 antigen,1729,38,4.80 [3.20-7.19],3.3715586351292105e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300E,CMRF35-like molecule 2,1733,39,4.15 [2.52-6.83],2.2100722814155964e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LG,CMRF35-like molecule 9,1728,37,7.64 [4.18-13.94],3.604479698427273e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD302,CD302 antigen,1722,38,8.76 [5.05-15.19],1.0520790542172507e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1722,38,5.51 [3.15-9.62],2.012157964990393e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD46,Membrane cofactor protein,1720,39,12.32 [6.05-25.10],4.547772539517703e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,1738,39,6.90 [3.39-14.03],9.803180975865044e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD55,Complement decay-accelerating factor,1659,37,10.81 [5.82-20.08],5.1272309196972326e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD59,CD59 glycoprotein,1659,39,11.43 [6.37-20.51],2.9950637324889876e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,1738,37,3.72 [2.50-5.51],6.843831228464856e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD93,Complement component C1q receptor,1663,38,7.12 [3.67-13.80],6.138649896789279e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99,CD99 antigen,1728,37,20.45 [7.26-57.62],1.1153532866743265e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH1,Cadherin-1,1659,39,3.06 [2.20-4.24],2.3073003817890075e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,1722,38,6.82 [3.79-12.28],1.5022682209098467e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,1724,39,3.79 [2.40-6.00],1.2015975582627413e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGB,Secretogranin-1,1729,37,3.55 [2.29-5.52],1.692988584811876e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,1732,37,6.55 [3.87-11.08],2.544609259135544e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,1728,37,10.16 [4.90-21.10],4.913325580843677e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,1692,39,7.21 [4.42-11.76],2.305013943037928e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,1720,39,10.88 [4.86-24.37],6.522720718901769e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLMP,CXADR-like membrane protein,1740,39,30.68 [12.76-73.78],2.063349693905975e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,1725,39,15.02 [6.12-36.88],3.329955026484237e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,1742,39,6.77 [4.25-10.78],7.260008110397886e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COLEC12,Collectin-12,1714,37,9.25 [4.58-18.70],5.595556571535182e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST3,Cystatin-C,1726,39,9.66 [5.51-16.95],2.460089135397097e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL16,C-X-C motif chemokine 16,1739,39,10.14 [4.66-22.08],5.325504205479139e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCN,Decorin,1692,39,16.79 [6.95-40.58],3.7036114946814976e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK4,Dickkopf-related protein 4,1707,37,3.80 [2.54-5.69],8.076046644169268e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL1,Delta-like protein 1,1729,38,7.81 [4.36-13.98],4.487016789882685e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPT,Dermatopontin,1742,39,30.72 [9.49-99.39],1.0883315818615544e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSC2,Desmocollin-2,1709,36,2.83 [2.06-3.88],1.0278511175087735e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,1740,39,4.41 [2.98-6.53],1.0929618177563001e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA1,Ephrin-A1,1727,37,8.51 [4.72-15.32],1.0336127055275432e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA4,Ephrin-A4,1705,37,11.02 [6.39-19.01],6.477336462740701e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,1666,37,5.37 [3.61-7.97],9.636216548576866e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB4,Ephrin type-B receptor 4,1742,39,8.62 [5.20-14.28],6.502297535841834e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,1742,39,9.90 [5.22-18.78],2.2049128736595467e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",1742,39,2.58 [1.83-3.64],7.3887238301137e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP6,Gastrotropin,1689,39,2.63 [1.85-3.74],7.80969035712353e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3C,Protein FAM3C,1724,39,12.67 [6.93-23.18],1.6427244520482348e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR1,Folate receptor alpha,1720,38,11.89 [6.16-22.93],1.5069716030717452e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF15,Growth/differentiation factor 15,1742,39,3.17 [2.22-4.53],2.426773274925873e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA1,GDNF family receptor alpha-1,1735,39,15.48 [7.58-31.61],5.314854069383018e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR37,Prosaposin receptor GPR37,1692,39,3.30 [2.27-4.79],3.4462476719130766e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCA2A,Guanylin,1720,37,5.34 [3.43-8.34],1.504451023911226e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,1738,39,2.82 [2.23-3.56],4.414358608862013e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",1713,36,9.33 [4.95-17.59],5.2260102194940855e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,1718,39,8.13 [4.78-13.82],9.667414763535752e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,1742,39,21.02 [8.16-54.18],2.9001369904367825e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,1740,39,3.03 [2.11-4.36],2.029039799575104e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,1704,36,3.67 [2.63-5.14],2.7495446912510872e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,1725,39,6.41 [4.03-10.20],3.882236027875181e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18BP,Interleukin-18-binding protein,1733,39,6.30 [3.36-11.83],9.888007261496535e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM2,Junctional adhesion molecule B,1736,37,9.49 [5.21-17.31],2.1022004757888985e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK11,Kallikrein-11,1708,38,3.42 [2.31-5.06],7.301976662084018e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,1738,37,4.95 [2.98-8.24],7.505573943462462e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAYN,Layilin,1704,37,6.93 [4.32-11.12],9.752051676272149e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,1676,38,4.70 [2.98-7.43],3.3132603684524414e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS1,Galectin-1,1724,39,7.20 [3.74-13.89],3.766050900318443e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS4,Galectin-4,1714,37,3.20 [2.13-4.79],1.756470489698746e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,1724,39,5.93 [3.58-9.84],5.207591649968411e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,1708,37,5.67 [3.38-9.50],4.447842911281776e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY6D,Lymphocyte antigen 6D,1708,37,3.58 [2.27-5.65],3.8720296438895337e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP7,Matrilysin,1690,39,4.16 [2.47-6.99],7.515775638879616e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSMB,Beta-microseminoprotein,1721,38,2.41 [1.76-3.32],5.30142504940364e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,1729,38,12.85 [6.33-26.07],1.5059687417837452e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,1713,36,5.51 [3.11-9.76],4.932427057641922e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCS1,Neuronal calcium sensor 1,1740,39,11.77 [5.32-26.03],1.1395001896030595e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN2,Nectin-2,1724,39,8.18 [4.88-13.69],1.3148856551679352e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN4,Nectin-4,1729,38,3.48 [2.51-4.83],9.406519291964649e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEFL,Neurofilament light polypeptide,1655,35,5.03 [3.34-7.59],1.2110901364647151e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,1724,39,4.44 [2.96-6.66],5.63576736733894e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGN,Mimecan,1728,37,5.41 [3.34-8.76],6.465677213563081e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGF,Placenta growth factor,1738,37,7.44 [4.23-13.07],3.102598306090829e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI3,Elafin,1703,39,2.65 [1.98-3.56],7.730172166691825e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,1728,37,8.95 [5.22-15.35],1.6489225176148113e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,1707,37,8.77 [4.16-18.48],1.1581671817013324e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS27,Serine protease 27,1720,39,5.56 [3.06-10.09],1.6922964087791756e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,1715,39,6.96 [4.34-11.15],7.30414436628011e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,1703,37,3.40 [2.19-5.29],5.2198057899383074e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP2,Retinol-binding protein 2,1722,38,2.68 [1.91-3.75],1.1541814657291944e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1A,Lithostathine-1-alpha,1721,39,3.27 [2.38-4.51],3.91407231629824e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,1742,39,2.82 [2.09-3.80],1.4689284025098275e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG4,Regenerating islet-derived protein 4,1718,37,3.51 [2.31-5.32],3.5960199999678646e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,1728,37,7.63 [4.05-14.40],3.3869709307649485e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REN,Renin,1724,39,1.97 [1.59-2.44],6.704848291724703e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMB,RGM domain family member B,1736,37,7.96 [3.83-16.53],2.6296704437555534e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE1,Ribonuclease pancreatic,1502,29,13.48 [5.63-32.30],5.33342889383729e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASET2,Ribonuclease T2,1736,39,4.01 [2.76-5.83],3.510491463676884e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,1724,39,10.81 [5.41-21.61],1.567745418060009e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO3,R-spondin-3,1740,39,5.79 [3.31-10.11],6.816726273495142e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARA5,Scavenger receptor class A member 5,1736,37,8.62 [4.77-15.58],9.69245670603552e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB2,Lysosome membrane protein 2,1671,37,5.76 [3.71-8.94],6.9168207840737204e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF2,Scavenger receptor class F member 2,1736,37,8.62 [3.96-18.75],5.6718947439635735e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG2,Secretogranin-2,1732,39,7.55 [4.04-14.09],2.1773010696503784e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGN,Secretagogin,1676,36,4.20 [2.65-6.66],9.62455410852908e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L,Seizure 6-like protein,1729,38,5.54 [3.02-10.17],3.2215424981131184e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHISA5,Protein shisa-5,1499,29,7.11 [3.70-13.69],4.1353166011474545e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,1713,37,4.04 [2.44-6.69],5.951428955702447e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,1692,39,9.09 [4.72-17.50],3.993412792505277e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,1675,38,8.00 [4.67-13.71],3.56605347316825e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,1728,37,2.81 [2.00-3.95],2.753056072714668e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,1713,36,3.21 [2.28-4.53],2.568975076705365e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,1722,38,4.62 [2.99-7.13],4.756344995161993e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF1,Trefoil factor 1,1720,37,2.00 [1.55-2.58],9.314123674448564e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF3,Trefoil factor 3,1714,38,2.79 [2.06-3.79],3.6287943424886356e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,1729,38,3.47 [2.42-5.00],1.89408992575384e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,1502,29,8.91 [4.11-19.35],3.1929024665836415e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBD,Thrombomodulin,1724,39,6.54 [3.46-12.33],6.745339407289164e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,1708,37,10.75 [5.39-21.45],1.5742380906135418e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,1708,37,1.67 [1.39-2.01],5.9544281917349064e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,1738,37,4.96 [3.19-7.72],1.2688729421733498e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,1729,38,6.37 [4.01-10.11],4.369064535659369e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,1718,37,6.30 [3.85-10.33],2.7939460440787096e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,1740,39,5.77 [3.86-8.63],1.1852523294685589e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,1728,37,9.40 [5.18-17.04],1.6187282765095216e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,1736,37,4.51 [2.75-7.41],2.644196379821385e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,1708,37,4.60 [2.81-7.54],1.328372404864445e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,1726,37,4.46 [2.92-6.79],3.796060048544346e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2,Brorin,1701,37,6.11 [3.28-11.38],1.1880943931509372e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,1639,34,4.40 [3.14-6.17],7.942160302697547e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WNT9A,Protein Wnt-9a,1676,36,3.06 [2.07-4.52],1.9699631232664664e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XG,Glycoprotein Xg,1732,39,6.33 [4.08-9.81],1.5143481358615344e-16
